All News BiomX Inc.

Equities

PHGE

US09090D1037

Market Closed - Nyse Other stock markets 04:10:00 2024-05-17 pm EDT			5-day change	1st Jan Change
0.3388 ^USD	+2.64%		-4.46%	+21.00%

Apr. 18	Biomx Inc. Appoints Susan Blum to Its Board of Directors and Member and Chair of the Audit Committee of the Board	CI
Apr. 03	Transcript : BiomX Inc., Q4 2023 Earnings Call, Apr 03, 2024

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

BiomX to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 21, 2024	May. 15	GL
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases	Apr. 24	AQ
BiomX to Present Data from Phase 1b/2a Study of BX004 for the Treatment of Cystic Fibrosis Patients with Chronic Pulmonary Infections at the 34th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024)	Apr. 23	AQ
BiomX Announces the Appointment of Susan Blum to its Board of Directors	Apr. 18	AQ
Biomx Inc. Appoints Susan Blum to Its Board of Directors and Member and Chair of the Audit Committee of the Board	Apr. 18	CI
BiomX : Introduction	Apr. 04	PU
BiomX Announces Compliance with NYSE Guidelines on Audit Opinion Disclosure	Apr. 04	AQ
Transcript : BiomX Inc., Q4 2023 Earnings Call, Apr 03, 2024	Apr. 03
BiomX Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	Apr. 03	AQ
BiomX Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 03	CI
BiomX to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on April 3rd, 2024	Mar. 27	AQ
Biomx Inc. Announces Board Changes	Mar. 18	CI
BiomX Announces Closing of the Acquisition of Adaptive Phage Therapeutics and Concurrent $50 Million Financing	Mar. 18	AQ
BiomX Inc. announced that it has received $50.013969 million in funding from Deerfield Management Company, LLC, AMR Action Fund GP, LLC, Cystic Fibrosis Foundation, Nantahala Capital Management, LLC, OrbiMed Advisors LLC	Mar. 14	CI
BiomX Inc. completed the acquisition of Adaptive Phage Therapeutics, Inc.	Mar. 14	CI
Sector Update: Health Care Stocks Advance Wednesday Afternoon	Mar. 06	MT
Sector Update: Health Care	Mar. 06	MT
BiomX Shares Rally After Merger Deal With Adaptive Phage Therapeutics	Mar. 06	MT
Transcript : BiomX Inc., Adaptive Phage Therapeutics, Inc. - M&A Call	Mar. 06
BiomX : Material Agreement - Form 8-K	Mar. 06	PU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News BiomX Inc.

Equities

PHGE

US09090D1037

All News

Filters